CGP 35949, an LTD4 antagonist with phospholipase inhibitory activity: a new approach to the treatment of asthma.
作者信息
Beck A, Sallmann A, Wenk P, Märki F, Bray M A
机构信息
Research Department, CIBA-GEIGY Ltd., Basle, Switzerland.
出版信息
Adv Prostaglandin Thromboxane Leukot Res. 1987;17B:771-4.
PMID:2960189
Abstract
摘要
Zotero 插件